OlinOLN
OLN logo
Fair Value
US$22.38
Share price12 Aug
US$17.1523.4% undervalued intrinsic discount
Loading
1Y-27.51%
7D-6.79%

Analyst Commentary Reflects Cautious Optimism as Olin Faces Mixed Signals and Modest Valuation Gains

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
30 Aug 24
Updated
12 Aug 26
Views
430
Not Invested

Last Update 12 Aug 26

Fair value Decreased 15%

OLN: Huntsman Merger And Cost Advantage Will Support Future Earnings

Analysts have reduced the Olin fair value estimate from about $26.29 to about $22.38, reflecting lower Street price targets clustered around $20, as well as concerns about softer chlor alkali fundamentals, weaker pricing trends, and a more muted earnings outlook discussed in recent research.

Analyst Commentary

Recent Street research around Olin shows a clear reset in expectations, with most firms converging around price targets near US$20 and more cautious views on earnings power and the proposed Huntsman merger. For you as an investor, the key signals sit in how analysts frame Olin's valuation support versus the execution and growth risks now in focus.

Bullish Takeaways

  • Bullish analysts who maintain Neutral or similar ratings point to Olin's relative cost advantage in US gas advantaged chlorine and caustic soda. They view this as an important support for long term competitiveness even as near term pricing softens.
  • Some commentary highlights that Olin's Q2 results were in line with expectations. This suggests to these analysts that current earnings are not materially off track, even if guidance and pricing commentary have turned more cautious.
  • JPMorgan previously increased its price target to US$26 from US$20 while keeping a Neutral stance. This signals that at least part of the Street has seen room for Olin's valuation to move higher when conditions allow.
  • On the proposed Huntsman merger, certain research points to complementary strengths, with Olin more cost advantaged upstream and Huntsman more differentiated in downstream polyurethane and epoxy. Bullish analysts see this as a potential long term platform if execution proves solid.

Bearish Takeaways

  • Bearish analysts have lowered price targets into the US$20 to US$25 range and emphasize weakening chlor alkali fundamentals, particularly softer caustic soda export demand and weak chlorine demand. They see this as a headwind for Olin's earnings power.
  • Several firms cite a more muted earnings outlook following an in line Q2 but softer Q3 guide, especially compared with commodity peers that reported stronger quarters. This feeds into reduced confidence around Olin's near term growth trajectory.
  • Research notes point to loosening chlor alkali markets, with China CTO exports and waning early quarter price strength flagged as pressure points that could limit Olin's pricing and margin support.
  • Some bearish analysts highlight concerns around the pending Huntsman merger, including exposure to global housing and construction and competitive supply pressure. They also express a view that the deal introduces execution risk and what they describe as "thesis drift" for Olin.

What’s in the News for Olin

  • Olin reported a Q2 2026 net loss of US$13.3 million, or a basic loss of US$0.12 per share, with revenues described as steady. Source, company earnings release summarized in recent news coverage.
  • An unplanned outage at Olin's vinyl chloride monomer plant in Freeport, Texas affected adjusted EBITDA by about US$40 million. Operations have restarted at reduced rates, and the outage was cited as a key factor in recent results. Source, recent news reports.
  • Following the Q2 2026 earnings release and outage disclosure, Olin's stock price declined 16%. Source, recent news coverage.
  • Olin and Huntsman Corporation announced a definitive all stock merger of equals that is expected to close in the first half of 2027, subject to regulatory and shareholder approvals. Source, joint merger announcement reported in news.
  • Olin has scheduled a Special or Extraordinary Shareholders Meeting on August 25, 2026, which investors can watch for further details on company plans. Source, company event listing.

Valuation Changes for Olin

  • Fair value has fallen moderately, with the estimate reduced from about $26.29 to about $22.38.
  • The discount rate has risen slightly from about 9.07% to about 9.96%, which points to a higher implied required return for Olin.
  • The revenue growth assumption has risen from about 2.25% to about 4.84%, indicating a higher modeled top line growth rate in dollar terms for revenue.
  • The net profit margin expectation has edged lower, moving from about 3.37% to about 3.16% for earnings.
  • The future P/E multiple has been marked down from about 15.24x to about 13.65x, which contributes to the lower fair value estimate for Olin.
9 viewsusers have viewed this narrative update

Key Takeaways

  • Structural cost reductions and a shift to higher-margin specialty chemicals are set to enhance earnings stability and profitability.
  • Strong demand for core chemicals, disciplined capital returns, and industry rationalization position Olin for sustained growth and improved shareholder value.
  • Persistent global overcapacity, intensifying competition, regulatory risks, and structural demand shifts threaten Olin's margins, revenue stability, and long-term earnings across core businesses.

Catalysts

About Olin
    Manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada.
What are the underlying business or industry changes driving this perspective?
  • Structural cost reduction initiatives (Beyond250 and Epoxy cost optimization) are expected to deliver significant operational savings, yielding an estimated $70–90 million run-rate benefit by the end of 2025 and additional structural cost reductions from the Stade, Germany facility in 2026; this should improve net margins and boost earnings quality.
  • Ongoing global demand for caustic soda-supported by increased water treatment, mining, agricultural, and alumina applications-positions Olin to benefit from sustained, base-level demand for core chemicals as electrification, renewables, and urbanization projects expand, which underpins future revenue growth.
  • Strategic repositioning into higher-value, downstream products and specialty chemicals (such as formulated epoxy solutions and differentiated chlorinated organics) is driving a growing share of stable, higher-margin revenue, enhancing long-term earnings stability and margin expansion.
  • Rationalization of global chemical production capacity, particularly in Asia and Europe, combined with Olin's advantaged North American cost position (from shale-based ethane feedstock), is likely to reduce industry oversupply, support firmer pricing, and further improve operating leverage and profitability.
  • Conservative balance sheet management and strong cash flow generation-with ongoing debt reduction and share buybacks-creates capacity for capital returns and protects against cyclical downturns, supporting EPS growth and shareholder value.
Olin Earnings and Revenue Growth

Olin Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Olin's revenue will grow by 4.8% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -2.9% today to 3.2% in 3 years time.
  • Analysts expect earnings to reach $244.3 million (and earnings per share of $2.12) by about August 2029, up from -$196.9 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.7x on those 2029 earnings, up from -11.0x today. This future PE is lower than the current PE for the US Chemicals industry at 29.4x.
  • Analysts expect the number of shares outstanding to decline by 0.57% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 9.96%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Prolonged global overcapacity and steep declines in EDC (ethylene dichloride) prices-now at or near record lows-signal persistent supply-demand imbalances, particularly due to continued participation by higher-cost Asian producers and sluggish global construction and housing markets; this structurally lowers Olin's revenues and compresses margins in its chlor-alkali and vinyls segments.
  • Accelerating competition from low-cost international chemical producers, especially in Asia, compounded by lackluster asset rationalization and disappointing anti-dumping actions in Europe, undermines Olin's pricing power and market share, further threatening both future revenues and sustained profitability.
  • Increased regulatory, tariff, and geopolitical risk-highlighted by uncertainty concerning potential retaliatory tariffs from major importers like Brazil, ongoing U.S.–China tensions, and shifting trade flows-adds volatility to export markets and may drive unpredictable disruptions in Olin's global caustic soda and EDC sales, impacting top-line growth and operational efficiency.
  • The company's Winchester commercial ammunition business faces significant margin compression due to a "perfect storm" of high inventory levels, weak consumer discretionary demand, competitive pricing pressures, and sharply rising input costs (notably for copper and propellants); prolonged weakness here erodes segment operating income and drags on consolidated earnings.
  • Olin's heavy reliance on cyclical end-markets (construction, automotive, electronics) and legacy product lines exposes it to prolonged downturns and secular shifts toward sustainability, bio-based alternatives, and recycling technologies; these trends could structurally erode demand for Olin's core products, depressing volume growth, net margins, and long-run earnings power.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $22.38 for Olin based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $30.0, and the most bearish reporting a price target of just $19.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $7.7 billion, earnings will come to $244.3 million, and it would be trading on a PE ratio of 13.7x, assuming you use a discount rate of 10.0%.
  • Given the current share price of $19.08, the analyst price target of $22.38 is 14.8% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Olin?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$22.38
vs US$17.1523.4% undervalued intrinsic discount
PastFuture-233m10b2015201820212024202620272029Revenue US$7.7bEarnings US$244.3m
4.8%
Revenue growth
3.2%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Olin

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Very undervalued with moderate growth potential.

Market capUS$2.0b
PB1.1x
Estimated Growth4.6%
Dividend Yield4.7%
Full analysis

CEO & management

Kenneth Lane
CEO
5.2yrs
CEO Tenure

Manufactures and distributes chemical products in the United States, Europe, Asia Pacific, the Middle East, Africa, and India Middle East, Africa, India, Latin America, and Canada.